Daniel C. Martin

Overview

Daniel C. Martin received an average of $3M in total compensation, including $382K in salary, at Deciphera Pharmaceuticals from 2018 to 2021.

Source: SEC filings on April 26, 2022 and April 22, 2019.

Related executives

We found six more executives who work or worked at Deciphera Pharmaceuticals.

Steven Hoerter

Deciphera Pharmaceuticals

Chief Executive Officer

Matthew Sherman

Deciphera Pharmaceuticals

Chief Medical Officer

Daniel Flynn

Deciphera Pharmaceuticals

Chief Scientific Officer

Thomas Kelly

Deciphera Pharmaceuticals

Chief Financial Officer

Michael Taylor

Deciphera Pharmaceuticals

Chief Executive Officer

Christopher Morl

Deciphera Pharmaceuticals

Chief Business Officer

News

You may also like